MetaCap

Polyrizon Ltd. (PLRZ)

NASDAQ: PLRZHealth CareMedical/Dental InstrumentsUSD

9.31-0.8557 (-8.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PLRZ stock chart

Technical analysis

Key statistics

All statistics
Market cap
$22.61M
EPS (TTM)
-$4.97
52-week range
2.88 – 18.20
Day range
9.26 – 9.90
Volume / Avg
4.85K / 38.21K
Beta
—

52-week range

$2.88$18.20

PLRZ stock today

Shares of Polyrizon (PLRZ) finished lower on Nov 20 at $9.31, a drop of 8.42% or $0.8557 per share, versus the S&P 500's 3.70% decline. Trading was light, with 4.85K shares changing hands, about 13% of the average daily volume. At this level, PLRZ sits in the middle of its 52-week range of $2.88 to $18.20: 48.8% below the high, set on Dec 4, 2025 and 223.3% above the low.

PLRZ is up 9.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 144.0%. Polyrizon has posted a net loss over the last twelve months (EPS of -$4.97), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Polyrizon

Company profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers.

Industry
Medical/Dental Instruments
CEO
Mr. Tomer Izraeli
Headquarters
Ra'anana
Employees
2
IPO year
2024

Financial highlights

Full financials

Polyrizon reported a net loss of $3.3 million, compared with a loss of $1.5 million a year earlier. Diluted earnings per share came in at $4.90, down from $805.20.

Polyrizon annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue————
Growth————
Net income$-3.33M$-1.54M$-600.00K$-779.00K
EPS (diluted)$4.90$805.20$494.40$0.60

PLRZ news

All PLRZ news

Polyrizon peers

Health Care sector
PLRZ peer companies
CompanyPrice% ChgMarket capCompare
DAVIDavion Healthcare Plc0.9001-9.99%$22.50Mvs PLRZ
PMIPicard Medical Inc.6.79+7.78%$18.07Mvs PLRZ
BEATHeartbeam Inc.0.2751-10.94%$17.42Mvs PLRZ
NEPHNephros Inc.2.61-8.10%$28.37Mvs PLRZ
RVPRetractable Technologies Inc.0.558-6.84%$16.70Mvs PLRZ
MODDModular Medical Inc.1.68-11.81%$16.36Mvs PLRZ
NSPRInspireMD Inc.0.54-12.97%$29.23Mvs PLRZ
XTNTXtant Medical Holdings Inc.0.21-2.82%$29.49Mvs PLRZ

Indexes, lists and sector

Polyrizon stock FAQ

What is Polyrizon's stock price today?

PLRZ last traded at $9.31 as of Nov 20, 4:00 PM EST, down 8.42% on the day. Prices are delayed at least 15 minutes.

Does Polyrizon pay a dividend?

No. Polyrizon does not currently pay a regular cash dividend.

Who is Polyrizon's CEO?

Mr. Tomer Izraeli is the chief executive officer of Polyrizon Ltd., which has about 2 employees.

Has PLRZ ever split its stock?

Yes. The most recent PLRZ stock split was a 1-for-6 split on Nov 28, 2025, one of 2 splits on record.

What is the PLRZ 52-week high?

The 52-week high for PLRZ is $18.20 and the 52-week low is $2.88. The stock is currently 48.8% below its high.

Compare PLRZ